Search research articles
Contact Us
Filters
Showing results (81-90 of 268) with videos related to
Page
of 27
Sort By:
Oncotarget
|
November 8, 2017
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma
Isabel Arrillaga-Romany, Andrew S Chi, Joshua E Allen, et al.
Journal of Neuropathology and Experimental Neurology
|
December 6, 2006
Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival
Masahiro Mizoguchi, Rebecca A Betensky, Tracy T Batchelor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2013
Reply to B. Freidlin et al
Lorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.
Nature Reviews. Neuroscience
|
July 24, 2007
Angiogenesis in brain tumours
Rakesh K Jain, Emmanuelle di Tomaso, Dan G Duda, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
December 1, 2016
Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI
Mikkel Bo Hansen, Anna Tietze, Jayashree Kalpathy-Cramer, et al.
Neuro-Oncology
|
February 17, 2010
Bevacizumab salvage therapy following progression in high-grade glioma patients treated with VEGF receptor tyrosine kinase inhibitors
Brian J Scott, Eudocia C Quant, Margaret B McNamara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2012
Bayesian adaptive randomized trial design for patients with recurrent glioblastoma
Lorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 28, 2005
Genetic analyses for predictors of radiation response in glioblastoma
Helen A Shih, Rebecca A Betensky, Molly V Dorfman, et al.
Cancer
|
April 4, 2017
High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission
Zachariah DeFilipp, Shuli Li, Areej El-Jawahri, et al.
Neurology
|
July 26, 2015
Standard chemoradiation for glioblastoma results in progressive brain volume loss
Morgan J Prust, Kourosh Jafari-Khouzani, Jayashree Kalpathy-Cramer, et al.
Page
of 27
Search research articles
Search
Showing results (81-90 of 268) with videos related to
Sort By:
Page
of 27
Oncotarget
|
November 8, 2017
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma
Isabel Arrillaga-Romany, Andrew S Chi, Joshua E Allen, et al.
Journal of Neuropathology and Experimental Neurology
|
December 6, 2006
Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival
Masahiro Mizoguchi, Rebecca A Betensky, Tracy T Batchelor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2013
Reply to B. Freidlin et al
Lorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.
Nature Reviews. Neuroscience
|
July 24, 2007
Angiogenesis in brain tumours
Rakesh K Jain, Emmanuelle di Tomaso, Dan G Duda, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
December 1, 2016
Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI
Mikkel Bo Hansen, Anna Tietze, Jayashree Kalpathy-Cramer, et al.
Neuro-Oncology
|
February 17, 2010
Bevacizumab salvage therapy following progression in high-grade glioma patients treated with VEGF receptor tyrosine kinase inhibitors
Brian J Scott, Eudocia C Quant, Margaret B McNamara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2012
Bayesian adaptive randomized trial design for patients with recurrent glioblastoma
Lorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 28, 2005
Genetic analyses for predictors of radiation response in glioblastoma
Helen A Shih, Rebecca A Betensky, Molly V Dorfman, et al.
Cancer
|
April 4, 2017
High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission
Zachariah DeFilipp, Shuli Li, Areej El-Jawahri, et al.
Neurology
|
July 26, 2015
Standard chemoradiation for glioblastoma results in progressive brain volume loss
Morgan J Prust, Kourosh Jafari-Khouzani, Jayashree Kalpathy-Cramer, et al.
Page
of 27